Stuart A. Arbuckle
2014
In 2014, Stuart A. Arbuckle earned a total compensation of $15.2M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals, a 215% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $675,000 |
|---|---|
| Option Awards | $4,044,646 |
| Salary | $600,000 |
| Stock Awards | $9,865,110 |
| Other | $12,857 |
| Total | $15,197,613 |
Arbuckle received $9.9M in stock awards, accounting for 65% of the total pay in 2014.
Arbuckle also received $675K in non-equity incentive plan, $4M in option awards, $600K in salary and $12.9K in other compensation.
Rankings
In 2014, Stuart A. Arbuckle's compensation ranked 223rd out of 13,032 executives tracked by ExecPay. In other words, Arbuckle earned more than 98.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 223 out of 13,032 | 98th |
Division Manufacturing | 84 out of 4,967 | 98th |
Major group Chemicals And Allied Products | 33 out of 1,690 | 98th |
Industry group Drugs | 27 out of 1,369 | 98th |
Industry Pharmaceutical Preparations | 25 out of 1,042 | 98th |
Source: SEC filing on April 28, 2017.
Arbuckle's colleagues
We found four more compensation records of executives who worked with Stuart A. Arbuckle at Vertex Pharmaceuticals in 2014.